down arrow

Decipher Labs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE643N01012
  • NSEID:
  • BSEID: 524752
INR
12.19
0.46 (3.92%)
BSENSE

Apr 11, 12:52 PM

BSE+NSE Vol: 2.89 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Decipher Labs Ltd stock-summary
stock-summary
Decipher Labs Ltd
Micro Cap
Pharmaceuticals & Drugs
Decipher Labs Ltd. (formerly known as Combat Drugs Ltd) was incorporated as a Private Limited Company in September, 1986 and was converted into a Public Limited Company in Jun.'92. The company was promoted by Suchit Mohan Lal and Ajay Karan.
Company Coordinates stock-summary
Company Details
4th Flr Plot-94 Sagar Society, Banjara Hills Road No 2 Hyderabad Telangana : 500034
stock-summary
Tel:
stock-summary
http://www.combatdrugs.in
stock-summary
info@combatdrugs.in
Registrar Details
Venture Capital & Corporate Investments Ltd , 12-10-167,, MIG- 167,, Bharat Nagar Colony, Hyderabad
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 10.10 Cr
Number of Shares
1.01 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
20-Dec-2019
1.01
10.10
2100000
10
Preferential basis
20-Dec-2019
1.01
10.10
2100000
10
Preferential basis
01-Oct-2011
8
8.00
7676860
10
Scheme of Arrangement
01-Oct-2011
8
8.00
7676860
10
Scheme of Arrangement
19-Sep-2011
32.31
0.32
0
1
Capital Reduction
19-Sep-2011
3.23
0.32
-2908260
10
Consolidation of Shares
19-Sep-2011
32.31
0.32
0
1
Capital Reduction
19-Sep-2011
3.23
0.32
-2908260
10
Consolidation of Shares
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Ajjarapu Janakiram (16.43%)

Highest Public shareholder

Seshu Srinivas Akula (3.8%)

Individual Investors Holdings

80.73%

stock-summary Board of Directors
stock-summary
stock-summary
Management
Designation
Remuneration
Sushant Mohan Lal
Executive Director
3.0 lacs
G Venkateswara Rao
Independent Director
0
Megha Agarwal
Company Sec. & Compli. Officer
0
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
Raw Material
6.1472
0%
 
100
Raw Material
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Pharma Goods - Tablets, Liquids & Capsules
0.50
100.00%
 
100
Pharma Goods - Tablets, Liquids & Capsules
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
6 Cr
(Quarterly Results - Dec 2024)
Net Profit:
-1 Cr
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 12 Cr (Micro Cap)

stock-summary
P/E

12.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.22

stock-summary
Return on Equity

3.86%

stock-summary
Price to Book

0.55

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."